Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.

World journal of gastroenterology - 14 Oct 2016

Li Ying, Liu Yu-Hong, Hu Yu-Ying, Chen Lin, Li Jian-Ming

Abstract excerpt

AIM: To find the mechanisms by which special AT-rich sequence-binding protein 2 (SATB2) influences colorectal cancer (CRC) metastasis. METHODS: Cell growth assay, colony-forming assay, cell adhesion assay and cell migration assay were used to evaluate the biological characteristics of CRC cells with gain or loss of SATB2. Sphere formation assay was used to detect the self-renewal ability of CRC cells. The mRNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD24 Antigen
Share to Cell Adhesion
Share to Chromatin Immunoprecipitation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hyaluronan Receptors

Share to Matrix Attachment Region Binding Proteins

Share to Neoplasm Metastasis

Share to Neoplastic Stem Cells

Share to Real-Time Polymerase Chain Reaction

Source

Open in PubMed Open full text

Identifiers

PMID: 27784965
DOI: 10.3748/wjg.v22.i38.8528
PMCID: PMC5064034

Genes

SATB2
AXIN2
DLD
MEIS2
NANOG

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.PMID 27784965Read ↗

SATB2 is a novel biomarker and therapeutic target for cancerSemantic proximity Read ↗

Multiple effects of the special AT‐rich binding protein 1 (SATB1) in colon carcinomaSemantic proximity Read ↗

SATB2 Induces Malignant Transformation and Cancer Stem Cell Characteristics, and Inhibition of Its Expression Reverses Drug Resistance in MesotheliomaSemantic proximity Read ↗

Cellular transformation of human mammary epithelial cells by SATB2Semantic proximity Read ↗

The Role of KDM2B and EZH2 in Regulating the Stemness in Colorectal Cancer Through the PI3K/AKT PathwaySemantic proximity Read ↗

Oncogenic Role of SATB2 In Vitro: Regulator of Pluripotency, Self-Renewal, and Epithelial–Mesenchymal Transition in Prostate CancerSemantic proximity Read ↗

Role of SATB2 in human pancreatic cancer: Implications in transformation and a promising biomarker.Semantic proximity Read ↗

Oncogenic role of SATB2 in prostate cancer: Regulator of pluripotency, self-renewal and epithelial-mesenchymal transitionSemantic proximity Read ↗

SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal CarcinomasSemantic proximity Read ↗

SATB2 drives glioblastoma growth by recruiting CBP to promote FOXM1 expression in glioma stem cellsSemantic proximity Read ↗

SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 TumorsSemantic proximity Read ↗

SATB1 expression is associated with biologic behavior in colorectal carcinoma in vitro and in vivo.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.